| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
27,014 |
23,215 |
$1.96M |
| 87631 |
|
8,195 |
7,770 |
$650K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
25,844 |
4,828 |
$596K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
22,636 |
19,404 |
$518K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,581 |
3,288 |
$447K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
742 |
702 |
$166K |
| 0100U |
|
516 |
496 |
$139K |
| 87486 |
|
6,577 |
5,903 |
$110K |
| 87581 |
|
6,577 |
5,903 |
$110K |
| 87507 |
|
486 |
464 |
$105K |
| 0099U |
|
201 |
197 |
$57K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,538 |
1,466 |
$54K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,526 |
1,218 |
$50K |
| 87503 |
|
4,578 |
1,218 |
$44K |
| 87634 |
|
1,526 |
1,218 |
$38K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,200 |
1,070 |
$37K |
| 87498 |
|
1,532 |
1,220 |
$19K |
| 87506 |
|
190 |
154 |
$16K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
130 |
121 |
$10K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
305 |
229 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
311 |
280 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
311 |
280 |
$5K |
| 87493 |
|
84 |
29 |
$4K |
| 87529 |
|
36 |
13 |
$603.42 |